Redox Biol:"寿命标签"端粒组份的功能丧失能以独立于端粒缩短的方式诱导氧化应激

2017-10-21 Emma MedSci原创

端粒被称为细胞寿命的"有丝分裂钟",端粒、着丝粒和复制原点是染色体保持完整和稳定的三大要素,端粒长度反映细胞复制史及复制潜能。有研究显示,端粒在决定动植物细胞的寿命中起着重要作用,细胞分裂次数越多,其端粒磨损越多,细胞寿命越短。

先天性角化不全症(简称DKC)也叫做Zinsser-Engman-Cole症候群,是一种罕见的进行性骨髓失能症候群。这个疾病主要有三种特征,网状皮肤色素沉着过多;指(趾)甲营养失调;口腔黏膜有白斑。于此疾病中可发现染色体端粒酶功能不良、核糖体缺乏和蛋白质合成功能异常等现象。早期死亡的原因常与骨髓失能、感染、致死的肺部并发症,或恶性肿瘤有关。患者皆可见活性低的端粒酶与长度较短的端粒DNA。

研究显示,DKC1、NOP10和TIN2的功能丧失与这个症候群有关联。它们是端粒酶(DKC1和NOP10)和保护素(TIN2)的关键组成部分,在端粒稳态中起重要作用。端粒被称为细胞寿命的"有丝分裂钟",端粒、着丝粒和复制原点是染色体保持完整和稳定的三大要素,端粒长度反映细胞复制史及复制潜能。有研究显示,端粒在决定动植物细胞的寿命中起着重要作用,细胞分裂次数越多,其端粒磨损越多,细胞寿命越短。

研究人员推测,如果DKC1,NOP10和TINF2的急性损失可以促进氧化还原不平衡,则该事件是端粒缩短尚未发生时的早期事件,因此对其进行了研究,结果显示,细胞缺少 DKC1和NOP10易受DNA损伤;急性DKC1和NOP10耗竭影响RNA的功能;氧化应激是发生在端粒缩短之前的早期事件;DKC1和NOP10基因的瞬时沉默引起了氧化应激,并且DKC1和NOP10功能的丧失是以独立于端粒缩短的方式诱导氧化应激。

其中,研究人员通过RNA干扰产生了siRNA介导(DKC1,NOP10和TINF2)细胞系,并通过mRNA和蛋白质表达分析进行了验证。细胞系均没有发生端粒缩短,H/ACA核糖核酸蛋白DKC1和NOP10的消耗通过下调TERC降低端粒酶活性,并改变pseudouridylation和核糖体生物发生。SiRNA DC细胞中除MnSOD和TRX1过表达外,还观察到GSSG/ GSH比,羰基化蛋白和氧化过氧化还原毒素-6的增加,还检测到PARP1和PARP1蛋白高水平表达。相比之下,沉默TINF2细胞没有显示用来评估氧化应激的标记的改变。

原始出处:
José Santiago Ibá?ez-Cabellos, et al. Acute telomerase components depletion triggers oxidative stress as an early event previous to telomeric shortening. Redox Biol. In Press. doi.org/10.1016/j.redox.2017.10.004

本文系梅斯医学(MedSci)原创翻译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1767266, encodeId=a39c1e67266c7, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sat Jul 21 22:00:00 CST 2018, time=2018-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917714, encodeId=b894191e71403, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Nov 06 15:00:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445177, encodeId=9fc314451e78c, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Oct 23 09:00:00 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255006, encodeId=b99e25500672, content=学习学习.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Oct 22 07:11:48 CST 2017, time=2017-10-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1767266, encodeId=a39c1e67266c7, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sat Jul 21 22:00:00 CST 2018, time=2018-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917714, encodeId=b894191e71403, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Nov 06 15:00:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445177, encodeId=9fc314451e78c, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Oct 23 09:00:00 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255006, encodeId=b99e25500672, content=学习学习.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Oct 22 07:11:48 CST 2017, time=2017-10-22, status=1, ipAttribution=)]
    2017-11-06 sunylz
  3. [GetPortalCommentsPageByObjectIdResponse(id=1767266, encodeId=a39c1e67266c7, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sat Jul 21 22:00:00 CST 2018, time=2018-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917714, encodeId=b894191e71403, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Nov 06 15:00:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445177, encodeId=9fc314451e78c, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Oct 23 09:00:00 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255006, encodeId=b99e25500672, content=学习学习.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Oct 22 07:11:48 CST 2017, time=2017-10-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1767266, encodeId=a39c1e67266c7, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sat Jul 21 22:00:00 CST 2018, time=2018-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1917714, encodeId=b894191e71403, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Nov 06 15:00:00 CST 2017, time=2017-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445177, encodeId=9fc314451e78c, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=医者仁心, createdTime=Mon Oct 23 09:00:00 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=255006, encodeId=b99e25500672, content=学习学习.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Oct 22 07:11:48 CST 2017, time=2017-10-22, status=1, ipAttribution=)]
    2017-10-22 1dd8c52fm63(暂无匿称)

    学习学习.继续关注

    0